FSSAI Issues Notice to Blinkit Over Egg Quality Concerns Strait of Hormuz Tensions Emerge as Indias Primary Market Risk Warns IME Capital elf Beauty ELF Q1 2026 Earnings 124 EPS Surges Past 073 Estimates Kevin Warshs Preferred Inflation Measure Faces Skepticism from Bank of America Economist Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales BP Ousts Chairman Albert Manifold Over Serious Conduct Concerns Shares Decline Digital Identity Co Modernizes Thailand Immigration with AWSPowered Mobile Arrival Card Singapore Shares Edge Higher as Caution Persists Over Middle East Tensions STI Rises 04 USChina Trade Rift Evident at APEC as Officials Signal Persistent Divergence Grizz Chapman 30 Rock Star Passes Away at 52 SBGI Q1 2026 Earnings EPS Surges Past Estimates with 13155 Surprise FLGT Q1 2026 Earnings Significant EPS Miss Amid Revenue Discrepancy Ferrovial Q4 2025 Earnings EPS Beats Estimates by 526 Despite Stock Decline ESTA Q1 2026 Earnings WiderthanExpected Loss Reflects RD and Commercial Investments EDIT Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher OMER Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress Cellebrite DI CLBT Edges Slightly Lower Holding Above Key Support Level BlackRock Science and Technology Trust BST Edges Higher as Tech Sentiment Stabilizes Horizon Space Acquisition II Corp HSPT Holds Steady at 1001 Amid SPAC Market Calm Richtech Robotics RR Holds Steady at 268 as Key Levels Signal Potential Breakout Apple Hospitality REIT APLE Faces Resistance Stock Slightly Lower on Modest Volume Ally Financial Q1 2026 Earnings EPS Surpasses Estimates by 165 Despite Small Stock Decline DouYu Q4 2025 Earnings Massive EPS Beat Yet Stock Declines Amid Revenue Uncertainty ACU Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges Elastic ESTC Q1 2026 Earnings EPS Surpasses Estimates by Nearly 11 RGLD Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines Slightly China Industrial Profits Surge 247 in April Marking Fastest Growth in Over Two Years MXL Q1 2026 Earnings EPS Surpasses Estimates by 224 Stock Gains Structure Therapeutics GPCR Edges Higher on Modest Gains Testing Key Resistance Levels